$DOX

Amdocs share price tanks as T-Mobile US dispute weighs heavily

Amdocs' share price dropped 42% after reporting a 3.6% revenue rise to $4.7bn, due to a contract dispute with T-Mobile US. The dispute may lead to arbitration or legal action, and Amdocs expects a 7-11% revenue decline in the coming year. Despite this, Amdocs secured new contracts with Vodafone, AT&T, and others, and acquired EIS for $340m to expand into insurance technology.

Original reporting
Published Nov 4, 2026, 1:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 3:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amdocs share price tanks as T-Mobile US dispute weighs heavily — source image
Decision brief

The 30-second read

$DOXBearishMed
01

Why it matters

The dispute introduces legal and revenue uncertainty, driving immediate sell pressure; however, new multi‑year contracts with other carriers could provide a floor to the downside.

02

Market read

Amdocs' stock faces sharp downside risk from the disclosed dispute and guidance cut, while its broader sector may see heightened scrutiny of carrier‑software contracts.

03

What to watch

Amdocs' new wins with Vodafone, AT&T, and other carriers may offset some revenue loss over the longer term.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Amdocs reported FY revenue up 3.6% to $4.7 bn but warned of a 7‑11% revenue decline for FY2027 due to a legal dispute with T‑Mobile US, causing a 42% pre‑market share drop.

Company-level read

Ticker impact

$DOXBearishHigh confidence
Context

Amdocs shares plunged ~42% in pre‑market after the company disclosed a contract dispute with T‑Mobile US and warned of major headwinds, cutting its FY revenue guidance by 7‑11%.

Expected impact

likely continued downside as the market digests the guidance cut and legal risk.

Evidence & confidence

The article provides the first disclosure of a material contract dispute and guidance reduction, which triggered a 42% price drop; no mitigating news offsets this impact.

Market effects

Highlights risk for telecom software vendors reliant on large carrier contracts; may prompt re‑rating of peers.

U.S. telecom and software sector could see broader pressure as investors reassess contract exposure.

Limited to U.S. markets; no immediate global macro effect.

Counterpoint

If the dispute resolves favorably, the stock could rebound sharply from oversold levels.

Key entities

  • Amdocs

    U.S. telecom software provider (NASDAQ: DOX).

  • T‑Mobile US

    Major U.S. wireless carrier involved in the contract dispute.

Related articles

$DOXHighAI 9/10

Amdocs (DOX) Q4 2026 Earnings Call Transcript

Amdocs (DOX) announced an 8-year deal with AT&T and other strategic agreements with VEON, Globe, and VodafoneThree to adopt its AOS technology. The company also acquired EIS, an insurance software provider, for $340M. Amdocs plans to expand into the insurance market and has optimized its portfolio to focus on its agentic strategy. The company reported progress in internal transformation and provided FY2027 revenue growth guidance.

$DOXHighAI 9/10

Amdocs drama: Stock crashes 45%

Amdocs' stock fell 45% after hours due to a weak 2027 forecast tied to a legal dispute with T-Mobile. The company reported a 9.6% drop in its 12-month order backlog to $3.5B and annual revenue of $4.7B, up 3.5%. Amdocs also announced a new contract with AT&T and acquired EIS for $340M to expand into insurance.

$DOXHighAI 9/10

Why is Amdocs stock cratering 40% today?

Amdocs stock fell 39.4% to $37.83 after issuing a weak fiscal 2027 outlook due to a legal dispute with T-Mobile, its largest customer. Q4 2026 results met expectations, but FY2027 revenue is projected to decline 14.3%-17.9% and adjusted EPS to fall 26%-30%. Oppenheimer downgraded the stock, and analysts revised earnings forecasts downward. The company also announced a $340M acquisition, adding to financial pressures.

$DOXHighAI 9/10

Why is Amdocs stock plummeting today?

Amdocs (DOX) stock fell 44.5% after-hours due to a fiscal 2027 outlook that missed expectations, citing a legal dispute with T-Mobile. Q4 2026 results met expectations, but Q1 2027 revenue guidance was 19% below consensus, and full-year EPS is projected to decline 26-30%. Oppenheimer downgraded the stock, and multiple analysts cut earnings estimates. The company is also exiting non-strategic businesses, adding to revenue uncertainty.